ArticleIJU case reports2026
Renal Neuroendocrine Tumor Mimicking Upper Tract Urothelial Carcinoma.
Article in IJU case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Renal pelvic or peripelvic neuroendocrine tumors are rare and may radiologically mimic invasive upper tract urothelial carcinoma. Case Presentation: A man in his 70s presented with two episodes of painless gross hematuria and lower urinary tract symptoms from benign prostatic hyperplasia. Computed tomography urography and magnetic resonance imaging showed a 3.1-cm enhancing mass centered at the right renal pelvis with apparent cortical invasion. However, flexible ureterorenoscopy showed intact urothelium, and renal pelvic wash cytology was negative. Upper tract urothelial carcinoma with parenchymal invasion was suspected, and single-port robot-assisted right nephroureterectomy with bladder cuff excision was performed. Histology revealed a well-circumscribed, well-differentiated neuroendocrine tumor beneath intact renal pelvic mucosa, with negative margins and a Ki-67 index of 4.9%. Ten-month postoperative imaging showed no recurrence or metastasis. Conclusion: Submucosal renal neuroendocrine tumors should be considered when imaging suggests a renal pelvic mass but endoscopy shows no mucosal lesion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.